NORML Working to Reform Marijuana Laws

Survey: Nearly One Out Of Six MS Patients Use Cannabis Therapeutically

One-quarter of patients with multiple sclerosis report having used cannabis therapeutically and nearly one out of six (16 percent) currently use it to treat symptoms of the disease, according to survey data commissioned by the North American Research Committee on MS. Those with more advanced symptoms of MS were more likely to report using cannabis therapeutically.

NORML Working to Reform Marijuana Laws

Study: Hemp Seed Oil Associated With Improved Clinical and Immunological Parameters In Multiple Sclerosis Patients

The consumption of legal hemp seed nutritional oil, in conjunction with the intake of evening primrose oils and a restrictive diet high in Hot-natured foods (such as pepper) and low in saturated fats and sugars, is associated with “significant improvement” in symptom management and immunological characteristics in subjects with multiple sclerosis, according to clinical trial data published this month in the scientific journal BioImpacts.